Bivalirudin Monitored with the Ecarin Clotting Time for Anticoagulation During Cardiopulmonary Bypass
- 1 February 2003
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 96 (2) , 383-386
- https://doi.org/10.1213/00000539-200302000-00015
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Monitoring Hirudin Anticoagulation in Two Patients Undergoing Cardiac Surgery with a Plasma-modified Act MethodAnesthesiology, 2002
- The Plasma Supplemented Modified Activated Clotting Time for Monitoring of Heparinization During Cardiopulmonary Bypass: A Pilot InvestigationAnesthesia & Analgesia, 2002
- One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type IIThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Use of Heparin during Cardiopulmonary Bypass in Patients with a History of Heparin-Induced ThrombocytopeniaNew England Journal of Medicine, 2000
- Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patientsJournal of Cardiothoracic and Vascular Anesthesia, 2000
- Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type IIJournal of Cardiothoracic and Vascular Anesthesia, 2000
- Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type IIJournal of Cardiothoracic and Vascular Anesthesia, 2000
- Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patientsJournal of Cardiothoracic and Vascular Anesthesia, 2000
- Monitoring of r-Hirudin Anticoagulation during Cardiopulmonary Bypass – Assessment of the Whole Blood Ecarin Clotting TimeThrombosis and Haemostasis, 1997